Gain Therapeutics, Inc. (GANX)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Sep 09, 13:18
Gain Therapeutics Price : 1.79 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.80 | 1.85 | 1.77 | 1.83 | 292335.0 |
| Sep 04, 2026 | 1.81 | 1.83 | 1.785 | 1.80 | 205351.0 |
| Sep 03, 2026 | 1.80 | 1.825 | 1.77 | 1.82 | 391413.0 |
| Sep 02, 2026 | 1.78 | 1.846 | 1.75 | 1.79 | 367690.0 |
| Sep 01, 2026 | 1.83 | 1.83 | 1.77 | 1.77 | 197910.0 |
| Aug 31, 2026 | 1.77 | 1.84 | 1.76 | 1.80 | 259893.0 |
| Aug 28, 2026 | 1.84 | 1.855 | 1.76 | 1.77 | 312529.0 |
| Aug 27, 2026 | 1.85 | 1.90 | 1.795 | 1.85 | 416110.0 |
| Aug 26, 2026 | 1.91 | 1.92 | 1.80 | 1.81 | 723423.0 |
| Aug 25, 2026 | 2.00 | 2.05 | 1.90 | 1.905 | 383518.0 |
| Aug 24, 2026 | 2.01 | 2.03 | 1.93 | 2.00 | 315901.0 |
| Aug 21, 2026 | 2.00 | 2.045 | 1.98 | 2.005 | 277476.0 |
| Aug 20, 2026 | 2.03 | 2.035 | 1.95 | 1.98 | 382528.0 |
| Aug 19, 2026 | 2.02 | 2.085 | 2.02 | 2.07 | 300040.0 |
| Aug 18, 2026 | 2.02 | 2.06 | 1.965 | 2.03 | 351574.0 |
| Aug 17, 2026 | 2.11 | 2.15 | 2.03 | 2.04 | 323486.0 |
| Aug 14, 2026 | 2.16 | 2.186 | 2.09 | 2.12 | 519002.0 |
| Aug 13, 2026 | 2.15 | 2.37 | 2.135 | 2.165 | 1.329M |
| Aug 12, 2026 | 2.01 | 2.17 | 2.01 | 2.12 | 586875.0 |
| Aug 11, 2026 | 1.78 | 2.14 | 1.78 | 2.06 | 1.674M |
| Aug 10, 2026 | 1.82 | 1.84 | 1.76 | 1.77 | 282961.0 |
| Aug 07, 2026 | 1.80 | 1.85 | 1.78 | 1.82 | 342932.0 |
| Aug 06, 2026 | 1.78 | 1.855 | 1.73 | 1.78 | 371943.0 |
| Aug 05, 2026 | 1.78 | 1.830 | 1.76 | 1.80 | 297495.0 |
| Aug 04, 2026 | 1.74 | 1.80 | 1.70 | 1.76 | 282567.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.81 |
| Alnylam Pharmaceuticals, Inc. | 255.35 |
| Anika Therapeutics, Inc. | 20.82 |
| Savara, Inc. | 5.39 |
| Vericel Corp. | 38.90 |
Price Related Metrics
| Price to Book Value | 6.870 |
| Earnings Yield | -28.27% |
| Market Cap | 77.58M |